Schedule 13G ownership disclosure

Enanta Pharmaceuticals Inc

Security class unavailable · CUSIP: 29251M106

Event date: 2014-09-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-14-056591
Form type
SC 13G
Filer
Dworsky Alan J
CIK
CIK 877887
Filed
Sep 18, 2014
Reporting period
Sep 12, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub